Myocarditis in adult-onset still disease
- PMID: 25398063
- PMCID: PMC4602418
- DOI: 10.1097/MD.0000000000000112
Myocarditis in adult-onset still disease
Abstract
This study highlights the clinical features, treatments, and outcomes of the rare myocarditis in adult-onset Still disease (AOSD). Among a case series of 57 patients fulfilling either Yamaguchi or Fautrel AOSD criteria and seen between 1998 and 2010, we identified 4 cases of myocarditis. From a comprehensive literature review, we collected 20 additional cases of myocarditis-complicated AOSD. The characteristics of patients with myocarditis were compared with those of AOSD patients without myocarditis.In these 24 myocarditis-complicated AOSD cases, myocarditis occurred early and was present at AOSD onset in 54% of the cases. Myocarditis was often symptomatic (96% of patients) with nonspecific electrocardiographic abnormalities (79% of patients) and a left ventricle ejection fraction ≤50% (67% of patients). Cardiac magnetic resonance imaging and endomyocardial biopsies showed features consistent with myocarditis in 4 patients and a mononuclear interstitial inflammatory infiltrate in 4 others. Steroids alone were effective in 50% of patients with myocarditis. Intravenous immunoglobulins, methotrexate, and tumor necrosis factor-α-blockers were also prescribed and often found effective. Only 1 patient died from cardiogenic shock. Patients with myocarditis-complicated AOSD were younger and more frequently male than patients with AOSD alone. Pericarditis was more frequent in the myocarditis group; white blood cell count, polymorphonuclear cell count, and serum ferritin levels were also higher.Myocarditis is a potentially life-threatening complication of AOSD but responds positively to steroids and other immunomodulatory drugs. Its prognosis remains good (only 1 death occurred), but the condition requires close monitoring of heart function.
Conflict of interest statement
Financial support and conflicts of interest: No funding source or sponsor has been involved in this study. PS has received consulting fees in the past from Pfizer, LFB, and GlaxoSmithKline. AH has received consulting fees in the past from LFB and Roche. The other authors have no conflicts of interest to disclose.
References
-
- Audia S, Vinit J, Leguy V, et al. [Myopericarditis initiating an adult-onset Still’s disease]. Rev Med Interne. 2008;Suppl 1:S125.
-
- Ballard M, Chazerain P, Charpentier J, et al. [Severe myocarditis in an adult-onset Still’s disease]. Rev Med Interne. 2002;23Suppl 5:S653.
-
- Bank I, Marboe CC, Redberg RF, et al. Myocarditis in adult Still’s disease. Arthritis Rheum. 1985;28:452–454. - PubMed
-
- Bergemer AM, Fouquet B, Goupille P, et al. [Myocarditis in Still’s disease in adults]. Rev Rhum Mal Osteo-Articul. 1988;55:945–948. - PubMed
-
- Bouhour JB, Haddak M, Lefèvre M. [Fatal form of pericardo-myocarditis in Wissler-Fanconi syndrome]. Arch Mal Coeur Vaiss. 1986;79:741–744. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
